Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice C O'Farrell

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
British Journal of Cancer|August 24, 2023
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkersIoannis Ntafoulis, Anne Kleijn, Jie Ju, et al.
Scientific Reports|April 13, 2026
A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancerValentina Thomas, Gift Nyamundanda, Adrian Lärkeryd, et al.
Journal of Neuro-Oncology|May 26, 2023
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivorsArchita Biswas, Manuela Salvucci, Kate Connor, et al.
Nature Genetics|February 20, 2021
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenograftsXing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Nature Genetics|January 8, 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenograftsXing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
British Journal of Cancer|August 24, 2023
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkersIoannis Ntafoulis, Anne Kleijn, Jie Ju, et al.
Scientific Reports|April 13, 2026
A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancerValentina Thomas, Gift Nyamundanda, Adrian Lärkeryd, et al.
Journal of Neuro-Oncology|May 26, 2023
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivorsArchita Biswas, Manuela Salvucci, Kate Connor, et al.
Nature Genetics|February 20, 2021
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenograftsXing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Nature Genetics|January 8, 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenograftsXing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Pageof 2